• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

微小 RNA-210 通过靶向线粒体生物能和 mtROS 流介导低氧诱导的肺动脉高压。

MicroRNA-210 mediates hypoxia-induced pulmonary hypertension by targeting mitochondrial bioenergetics and mtROS flux.

机构信息

Lawrence D. Longo, MD Center for Perinatal Biology, Department of Basic Sciences, Loma Linda University School of Medicine, Loma Linda, California, USA.

出版信息

Acta Physiol (Oxf). 2024 Sep;240(9):e14212. doi: 10.1111/apha.14212. Epub 2024 Jul 29.

DOI:10.1111/apha.14212
PMID:39073309
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11934933/
Abstract

AIM

Chronic hypoxia is a common cause of pulmonary hypertension (PH). We test the hypothesis that microRNA-210 (miR-210) mediates hypoxia-induced PH by targeting mitochondrial metabolism and increasing reactive oxygen species (mtROS) production in the lungs.

METHODS

Adult wildtype (WT) or miR-210 knockout (KO) mice were exposed to hypoxia (10.5% O) or normoxia for 4 weeks. We measured miR-210 levels, right ventricular systolic pressure (RVSP), and histological changes in heart and lung tissues. Mitochondrial bioenergetics and mtROS production were assessed in isolated lung mitochondria.

RESULTS

Hypoxia increased right ventricular wall thickness and pulmonary vessel wall muscularization in WT, but not miR-210 KO mice. No sex differences were observed. In male mice, hypoxia increased miR-210 levels in the lung and RVSP, which were abrogated by miR-210 deficiency. Hypoxia upregulated mitochondrial oxygen consumption rate and mtROS flux, which were negated in miR-210 KO animals. In addition, chronic hypoxia increased macrophage accumulation in lungs of WT, but not miR-210 KO mice. Moreover, miR-210 overexpression in lungs of WT animals recapitulated the effects of hypoxia and increased mitochondrial oxygen consumption rate, mtROS flux, right ventricular wall thickness, pulmonary vessel wall muscularization and RVSP. MitoQ revoked the effects of miR-210 on lung mitochondrial bioenergetics, right ventricular and pulmonary vessel remodeling and RVSP.

CONCLUSION

Our findings with loss-of-function and gain-of-function approaches provide explicit evidence that miR-210 mediates hypoxia-induced PH by upregulating mitochondrial bioenergetics and mtROS production in a murine model, revealing new insights into the mechanisms and therapeutic targets for treatment of PH.

摘要

目的

慢性缺氧是肺动脉高压(PH)的常见原因。我们通过测试假设来验证,miR-210 通过靶向线粒体代谢并增加肺部的活性氧(mtROS)产生来介导缺氧诱导的 PH。

方法

成年野生型(WT)或 miR-210 敲除(KO)小鼠暴露于低氧(10.5% O)或常氧 4 周。我们测量了 miR-210 水平、右心室收缩压(RVSP)以及心和肺组织的组织学变化。在分离的肺线粒体中评估线粒体生物能学和 mtROS 产生。

结果

低氧增加了 WT 但不是 miR-210 KO 小鼠的右心室壁厚度和肺血管壁肌化。未观察到性别差异。在雄性小鼠中,低氧增加了肺和 RVSP 中的 miR-210 水平,而 miR-210 缺失则消除了这种增加。低氧上调了线粒体耗氧率和 mtROS 通量,而在 miR-210 KO 动物中则被否定。此外,慢性低氧增加了 WT 但不是 miR-210 KO 小鼠肺部的巨噬细胞积累。此外,WT 动物肺部的 miR-210 过表达再现了低氧的作用,增加了线粒体耗氧率、mtROS 通量、右心室壁厚度、肺血管壁肌化和 RVSP。MitoQ 逆转了 miR-210 对肺线粒体生物能学、右心室和肺血管重塑以及 RVSP 的影响。

结论

我们通过功能丧失和功能获得的方法得出的发现,提供了明确的证据表明 miR-210 通过上调线粒体生物能学和 mtROS 产生来介导缺氧诱导的 PH,这为 PH 治疗的机制和治疗靶点提供了新的见解。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae25/11934933/4e47b46e1956/nihms-2063521-f0008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae25/11934933/a28dbd37fb4c/nihms-2063521-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae25/11934933/99066067134b/nihms-2063521-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae25/11934933/05c8a90c9c95/nihms-2063521-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae25/11934933/d6a7736a832f/nihms-2063521-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae25/11934933/a998fb9fa796/nihms-2063521-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae25/11934933/499ace6d39c1/nihms-2063521-f0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae25/11934933/2a7d95f36798/nihms-2063521-f0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae25/11934933/4e47b46e1956/nihms-2063521-f0008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae25/11934933/a28dbd37fb4c/nihms-2063521-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae25/11934933/99066067134b/nihms-2063521-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae25/11934933/05c8a90c9c95/nihms-2063521-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae25/11934933/d6a7736a832f/nihms-2063521-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae25/11934933/a998fb9fa796/nihms-2063521-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae25/11934933/499ace6d39c1/nihms-2063521-f0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae25/11934933/2a7d95f36798/nihms-2063521-f0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae25/11934933/4e47b46e1956/nihms-2063521-f0008.jpg

相似文献

1
MicroRNA-210 mediates hypoxia-induced pulmonary hypertension by targeting mitochondrial bioenergetics and mtROS flux.微小 RNA-210 通过靶向线粒体生物能和 mtROS 流介导低氧诱导的肺动脉高压。
Acta Physiol (Oxf). 2024 Sep;240(9):e14212. doi: 10.1111/apha.14212. Epub 2024 Jul 29.
2
Redistribution of SOD3 expression due to R213G polymorphism affects pulmonary interstitial macrophage reprogramming in response to hypoxia.由于 R213G 多态性导致 SOD3 表达重新分布,从而影响低氧环境下肺间质巨噬细胞的重编程。
Physiol Genomics. 2024 Nov 1;56(11):776-790. doi: 10.1152/physiolgenomics.00078.2024. Epub 2024 Sep 23.
3
Sex-dependent phosphorylation of Argonaute 2 reduces the mitochondrial translocation of miR-181c and induces cardioprotection in females.Argonaute 2 的性别依赖性磷酸化减少了 miR-181c 的线粒体易位,并诱导雌性的心脏保护作用。
J Mol Cell Cardiol. 2024 Sep;194:59-69. doi: 10.1016/j.yjmcc.2024.06.006. Epub 2024 Jun 14.
4
Contribution of reactive oxygen species to the pathogenesis of pulmonary arterial hypertension.活性氧在肺动脉高压发病机制中的作用
PLoS One. 2017 Jun 30;12(6):e0180455. doi: 10.1371/journal.pone.0180455. eCollection 2017.
5
Enhanced lung endothelial glycolysis is implicated in the development of severe pulmonary hypertension in type 2 diabetes.2型糖尿病中增强的肺内皮细胞糖酵解与严重肺动脉高压的发生有关。
Am J Physiol Lung Cell Mol Physiol. 2025 Mar 1;328(3):L430-L442. doi: 10.1152/ajplung.00305.2023. Epub 2024 Oct 22.
6
Single-Cell and Spatial Transcriptomics Identified Fatty Acid-Binding Proteins Controlling Endothelial Glycolytic and Arterial Programming in Pulmonary Hypertension.单细胞和空间转录组学鉴定出控制肺动脉高压中内皮糖酵解和动脉编程的脂肪酸结合蛋白
Arterioscler Thromb Vasc Biol. 2025 May 22. doi: 10.1161/ATVBAHA.124.321173.
7
Novel and superior treatment of pulmonary hypertension with netrin-1 derived, modified and improved small peptides.用netrin-1衍生、改良和改进的小肽对肺动脉高压进行新型且卓越的治疗。
Redox Biol. 2025 Jun 13;85:103710. doi: 10.1016/j.redox.2025.103710.
8
PPARG in osteocytes controls cell bioenergetics and systemic energy metabolism independently of sclerostin levels in circulation.成骨细胞中的过氧化物酶体增殖物激活受体γ(PPARG)独立于循环中的骨硬化蛋白水平控制细胞生物能量和全身能量代谢。
Mol Metab. 2024 Oct;88:102000. doi: 10.1016/j.molmet.2024.102000. Epub 2024 Jul 27.
9
Loss of Affects Postnatal Lung Development and Predisposes to Pulmonary Hypertension.[具体缺失内容]影响出生后肺发育并易患肺动脉高压。
Am J Respir Cell Mol Biol. 2025 Mar 19. doi: 10.1165/rcmb.2024-0459OC.
10
YTHDF1-mediated m6A modification of TOP2A drives pulmonary hypertension via the PI3K/Akt/mTOR pathway.YTHDF1介导的TOP2A的m6A修饰通过PI3K/Akt/mTOR途径驱动肺动脉高压。
Cell Signal. 2025 Oct;134:111917. doi: 10.1016/j.cellsig.2025.111917. Epub 2025 May 30.

引用本文的文献

1
MicroRNA-210 Mediates Hypoxic Pulmonary Hypertension in the Newborn Lamb.微小RNA-210介导新生羔羊的低氧性肺动脉高压。
Hypertension. 2025 Jun;82(6):1151-1163. doi: 10.1161/HYPERTENSIONAHA.124.23061. Epub 2025 Apr 23.
2
Pulmonary Hypertension: Molecular Mechanisms and Clinical Studies.肺动脉高压:分子机制与临床研究
MedComm (2020). 2025 Mar 10;6(3):e70134. doi: 10.1002/mco2.70134. eCollection 2025 Mar.

本文引用的文献

1
Effects of a mitochondrial-targeted ubiquinol on vascular function and exercise capacity in chronic kidney disease: a randomized controlled pilot study.线粒体靶向泛醇对慢性肾脏病血管功能和运动能力的影响:一项随机对照试验性研究
Am J Physiol Renal Physiol. 2023 Oct 1;325(4):F448-F456. doi: 10.1152/ajprenal.00067.2023. Epub 2023 Aug 10.
2
Complex II Biology in Aging, Health, and Disease.衰老、健康与疾病中的复合物II生物学
Antioxidants (Basel). 2023 Jul 24;12(7):1477. doi: 10.3390/antiox12071477.
3
Mitochondrial succinate dehydrogenase function is essential for sperm motility and male fertility.
线粒体琥珀酸脱氢酶功能对于精子活力和男性生育能力至关重要。
iScience. 2022 Nov 14;25(12):105573. doi: 10.1016/j.isci.2022.105573. eCollection 2022 Dec 22.
4
Moderate Endurance Training and MitoQ Improve Cardiovascular Function, Oxidative Stress, and Inflammation in Hypertensive Individuals: The Role of miR-21 and miR-222: A Randomized, Double-Blind, Clinical Trial.适度耐力训练和MitoQ改善高血压患者的心血管功能、氧化应激和炎症:miR-21和miR-222的作用:一项随机、双盲临床试验
Cell J. 2022 Oct 1;24(10):577-585. doi: 10.22074/cellj.2022.8089.
5
A practical guide for the analysis, standardization and interpretation of oxygen consumption measurements.一份关于耗氧量测量的分析、标准化和解释的实用指南。
Nat Metab. 2022 Aug;4(8):978-994. doi: 10.1038/s42255-022-00619-4. Epub 2022 Aug 15.
6
MicroRNA-210 Controls Mitochondrial Metabolism and Protects Heart Function in Myocardial Infarction.MicroRNA-210 调控线粒体代谢并保护心肌梗死后的心脏功能。
Circulation. 2022 Apr 12;145(15):1140-1153. doi: 10.1161/CIRCULATIONAHA.121.056929. Epub 2022 Mar 17.
7
A narrative review of research advances in hypoxic pulmonary hypertension.缺氧性肺动脉高压研究进展的叙述性综述
Ann Transl Med. 2022 Feb;10(4):230. doi: 10.21037/atm-22-259.
8
Metabolism, Mitochondrial Dysfunction, and Redox Homeostasis in Pulmonary Hypertension.肺动脉高压中的代谢、线粒体功能障碍与氧化还原稳态
Antioxidants (Basel). 2022 Feb 21;11(2):428. doi: 10.3390/antiox11020428.
9
Targeting RUNX1 as a novel treatment modality for pulmonary arterial hypertension.以 RUNX1 为靶点的肺动脉高压新型治疗方法。
Cardiovasc Res. 2022 Dec 29;118(16):3211-3224. doi: 10.1093/cvr/cvac001.
10
Isolation of Mitochondria From Fresh Mice Lung Tissue.从新鲜小鼠肺组织中分离线粒体。
Front Physiol. 2021 Nov 30;12:748261. doi: 10.3389/fphys.2021.748261. eCollection 2021.